Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia

• Autori principali: A. P. Pereverzev (Autore), O. D. Ostroumova (Autore), O. N. Tkacheva (Autore), Y. V. Kotovskaya (Autore)
• Natura: Libro
• Pubblicazione: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2019-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

For the treatment of dementia and Alzheimer's disease, acetylcholinesterase inhibitors (donepezil, rivastigmine, galantamine) and/or the non-competitive inhibitor of N-methyl-D-aspartate receptors (NMDA receptors) memantine are currently used. The administration of these drugs can help temporar...